Valuation Mangalam Drugs & Organics Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:08 2026-07-31 EDT			5-day change	1st Jan Change
27.11 ^INR	+0.15%		-0.22%	-1.45%

06-17	Mangalam Drugs and Organics Ltd. Defaults on Loan Obligations to Bank of Baroda and Bank of Maharashtra	CI
05-14	Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	480.4	1,573	1,628	1,549	1,466	1,175
Change	-	227.51%	3.47%	-4.86%	-5.31%	-19.89%
Enterprise Value (EV) ¹	983.8	2,264	2,487	2,407	2,525	2,111
Change	-	130.17%	9.85%	-3.22%	4.87%	-16.37%
P/E	5.83x	5.63x	8.28x	122x	-16.2x	17.5x
PBR	0.46x	1.2x	1.08x	1.02x	1.08x	0.79x
PEG	-	0x	-0.3x	-1.3x	0x	-0x
Capitalization / Revenue	0.17x	0.41x	0.36x	0.42x	0.4x	0.37x
EV / Revenue	0.35x	0.6x	0.56x	0.65x	0.69x	0.66x
EV / EBITDA	4.35x	4.34x	5.65x	9.99x	32.9x	6.39x
EV / EBIT	6.22x	5.08x	7.01x	16.5x	90.2x	10.8x
EV / FCF	5.05x	-8.49x	-10.4x	-54.9x	-37.3x	18.2x
FCF Yield	19.8%	-11.8%	-9.58%	-1.82%	-2.68%	5.51%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	5.21	17.67	12.42	0.8	-5.731	4.246
Distribution rate	-	-	-	-	-	-
Net sales ¹	2,824	3,801	4,476	3,702	3,674	3,176
EBITDA ¹	226.1	521.9	440.6	241.1	76.84	330.2
EBIT ¹	158.1	445.5	355	146.3	27.98	195.6
Net income ¹	82.52	279.7	196.6	12.7	-90.72	67.21
Net Debt ¹	503.4	691.1	859.5	858.6	1,058	936.4
Reference price ²	30.35	99.40	102.85	97.85	92.65	74.22
Nbr of stocks (in thousands)	15,828	15,828	15,828	15,828	15,828	15,828
Announcement Date	9/2/20	9/2/21	9/2/22	9/6/23	9/4/24	9/7/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	36.67x	6.94x	23.96x	0.79%	50.29B
OTSUKA HOLDINGS CO., LTD.	18.61x	2.11x	9.96x	1.29%	37.24B
CIPLA LIMITED	28.47x	3.48x	18.01x	0.87%	12.41B
ZYDUS LIFESCIENCES LIMITED	26.43x	3.9x	15.89x	0.6%	11.65B
KRKA, D. D.	19.26x	3.37x	12.09x	3.46%	9.17B
ONO PHARMACEUTICAL CO., LTD.	16.27x	2.1x	7.07x	3.19%	7.24B
GEDEON RICHTER	8.2x	1.92x	5.03x	5.29%	6.8B
GLENMARK PHARMACEUTICALS LIMITED	33.25x	3.78x	16.08x	0.24%	6.47B
Average	23.40x	3.45x	13.51x	1.96%	17.66B
Weighted average by Cap.	26.64x	4.24x	16.17x	1.4%